Pluristem wins approval to test placenta cell-based therapy in Israel

10/4/2013 | Pharmaceutical Business Review Online

Pluristem Therapeutics obtained clearance from the Israeli Ministry of Health to initiate a midstage trial of its PLacental eXpanded cells in patients with intermittent claudication. The trial in Israel will follow the same protocol used by Pluristem in its U.S. study, which involved around 150 patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC